ISCHEMIA: new questions from a landmark trial

Morrow, A. , Sidik, N. and Berry, C. (2020) ISCHEMIA: new questions from a landmark trial. Cardiovascular Research, 116(2), e23-e25. (doi: 10.1093/cvr/cvz343) (PMID:31942937) (PMCID:PMC6983679)

[img]
Preview
Text
209050.pdf - Published Version
Available under License Creative Commons Attribution.

259kB

Abstract

No abstract available.

Item Type:Articles
Additional Information:C.B. and N.S. have research funding from the British Heart Foundation (both, FS/17/26/32744; and to C.B.; RE/18/6134217). C.B. and A.M. have research funding from the Medical Research Council (MR/S018905/1).
Keywords:Angina, CABG, ischaemia, microvascular, stent.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Berry, Professor Colin and Sidik, Ms Novalia and Morrow, Dr Andrew
Authors: Morrow, A., Sidik, N., and Berry, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Cardiovascular Research
Publisher:Oxford University Press
ISSN:0008-6363
ISSN (Online):1755-3245
Published Online:27 January 2020
Copyright Holders:Copyright © 2020 The Authors
First Published:First published in Cardiovascular Research 116(2): e23-e25
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
174109The conundrum of angina in patients without obstructive coronary disease: a randomised controlled pilot trial of routine testing of coronary function.Colin BerryBritish Heart Foundation (BHF)FS/17/26/32744Institute of Cardiovascular & Medical Sciences
303684A randomized, double-blind, placebo-controlled Phase 2A cross-over trial of oral zibotentan in patients with angina due to small vessel disease: a proof-of-concept, developmental trial for safety, efficacy and biomarkers developmentColin BerryMedical Research Council (MRC)MR/S018905/1CAMS - Cardiovascular Science